Bell Investment Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.32K | Buy |
54
+10
| +23% | +$1.73K | ﹤0.01% | 699 |
|
|
2025
Q1 | $6.86K | Hold |
44
| – | – | ﹤0.01% | 763 |
|
|
2024
Q4 | $6.06K | Sell |
44
-13
| -23% | -$1.79K | ﹤0.01% | 834 |
|
|
2024
Q3 | $8.51K | Buy |
57
+5
| +10% | +$747 | ﹤0.01% | 683 |
|
|
2024
Q2 | $7.09K | Buy |
52
+5
| +11% | +$682 | ﹤0.01% | 756 |
|
|
2024
Q1 | $7.11K | Buy |
47
+4
| +9% | +$605 | ﹤0.01% | 731 |
|
|
2023
Q4 | $5.42K | Buy |
43
+1
| +2% | +$126 | ﹤0.01% | 836 |
|
|
2023
Q3 | $3.93K | Buy |
42
+10
| +31% | +$936 | ﹤0.01% | 936 |
|
|
2023
Q2 | $2.86K | Buy |
32
+16
| +100% | +$1.43K | ﹤0.01% | 1117 |
|
|
2023
Q1 | $1.72K | Sell |
16
-31
| -66% | -$3.33K | ﹤0.01% | 1339 |
|
|
2022
Q4 | $5.74K | Hold |
47
| – | – | ﹤0.01% | 739 |
|
|
2022
Q3 | $5K | Buy |
47
+4
| +9% | +$426 | ﹤0.01% | 644 |
|
|
2022
Q2 | $4K | Buy |
+43
| New | +$4K | ﹤0.01% | 766 |
|
|
2021
Q4 | $5K | Buy |
35
+30
| +600% | +$4.29K | ﹤0.01% | 734 |
|
|
2021
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1262 |
|